Bone densitometry manufacturer Hologicannounced this month that it has named Steve L. Nakashige presidentand COO. Nakashige comes to the Waltham, MA, firm from GE MedicalSystems, where he was a senior manager in the vendor's ultrasoundbusiness.
Bone densitometry manufacturer Hologicannounced this month that it has named Steve L. Nakashige presidentand COO. Nakashige comes to the Waltham, MA, firm from GE MedicalSystems, where he was a senior manager in the vendor's ultrasoundbusiness.
Nakashige will assume positions previously held by Hologicco-founder David Ellenbogen, who will remain chairman and CEO.Nakashige's appointment will allow Ellenbogen to devote more timeto new product development and growing the company's internationaldistribution channels.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.